Mould Annie
J Law Med. 2003 May;10(4):470-87.
This article examines the possibility of genetic discrimination in life insurance and discusses the inability of current Australian legislation to deal adequately with genetic test result information. Genetic information has certain features that distinguish it from other medical information and thus a specialist legislative package is required to regulate its use. This article outlines how current practices in the life insurance industry are inconsistent with notions of human rights. Several legislative options are suggested and examined. Given the negative and damaging impact that adverse selection is likely to have on the life insurance industry should the use of all genetic test results be prohibited, an approach which modifies the current regime is recommended. This includes a comprehensive review scheme and the introduction of additional insurance products tailored to individuals suffering from various genetic illnesses or predispositions to future disease.
本文探讨了人寿保险中基因歧视的可能性,并讨论了澳大利亚现行立法无法充分处理基因检测结果信息的问题。基因信息具有某些使其有别于其他医学信息的特征,因此需要一套专门的立法来规范其使用。本文概述了人寿保险行业目前的做法如何与人权观念不一致。提出并审视了几种立法选择。鉴于如果禁止使用所有基因检测结果,逆向选择可能会对人寿保险行业产生负面和破坏性影响,建议采用一种修改现行制度的方法。这包括一个全面的审查方案,以及推出针对患有各种基因疾病或未来疾病易感性个体的额外保险产品。